![Patrick Walsh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrick Walsh
Corporate Officer/Principal bij
IMMUNIC, INC.
Profiel
Patrick Walsh is Chief Business Officer at Immunic, Inc. since 2021.
Formerly, Mr. Walsh was Director-Business Development at Akebia Therapeutics, Inc. from 2015 to 2021 and held the position of Head-Corporate Development at AVEO Pharmaceuticals, Inc. Education includes undergraduate studies at Colby College and graduate studies including an MBA at the University of Michigan.
Actieve functies van Patrick Walsh
| Bedrijven | Functie | Begin |
|---|---|---|
| IMMUNIC, INC. | Corporate Officer/Principal | 14-10-2021 |
Eerdere bekende functies van Patrick Walsh
| Bedrijven | Functie | Einde |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Corporate Officer/Principal | 01-10-2021 |
| AVEO PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Opleiding van Patrick Walsh
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
56
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Colby College
 Colby College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Immunic, Inc.
 Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases | Health Technology |
